Navigation Links
Pharmacyclics Announces Completion of Phase 1 Clinical Trial of Factor VIIa Inhibitor PCI-27483
Date:11/25/2008

SUNNYVALE, Calif., Nov. 25 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today announced that the company has completed a Phase 1 clinical trial with PCI-27483, the company's novel, first-in-class small-molecule Factor VIIa inhibitor. The trial was conducted in sixteen (16) healthy volunteers to evaluate the safety and pharmacologic effect of PCI-27483. A single administration of PCI-27483 resulted in a linear dose response in the International Normalized Ratio (INR), a routine laboratory test used to assess the level of anticoagulation (blood-thinning).

"Single doses of PCI-27483 reliably and quickly achieved therapeutic levels of anticoagulation without adverse effects in this initial trial," said James Lowder, M.D., Vice President, Clinical Development for Pharmacyclics. "The ability to achieve precise levels of anticoagulation that can be readily measured differentiates PCI-27483 from other available anticoagulants. The Factor VIIa: tissue factor complex, the pharmacologic target of PCI-27483, has been implicated both in the progression of solid tumors and the increased incidence of venous thromboembolic events observed in many malignancies. Up-regulation of tissue factor expression is observed in pancreatic, lung, and breast cancer, and is associated with a worsened prognosis."

In the recently completed study, PCI-27483 increased the INR with minimal intra-subject variation and a half-life of ten hours. At the highest subcutaneous dose of PCI-27483 evaluated, a mean (+/-standard error) peak INR of 2.72 (+/- 0.24) was achieved one to two hours post-dosing. The trial further established doses of PCI-27483, which upon repeated dosing are expected to maintain the INR in the range of 2.0 to 3.0, the target window for treatment and prevention of thromboembolic events (i.e., formation of blood clots).


'/>"/>
SOURCE Pharmacyclics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
2. Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
3. Pharmacyclics Reports Multiple Presentations at AACR on Its HDAC and Selective HDAC Inhibitors
4. Pharmacyclics Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer
5. Pharmacyclics Novel Btk Inhibitor Shows Efficacy in Preclinical Models of Rheumatoid Arthritis and Lymphoma
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... ORANGE , N.J. and NEW BRUNSWICK, N.J., Sept. 30, ... affiliation agreement that allows Kessler Foundation and New ... advance biomedical research, education and patient care programs ... president and chief executive officer of Kessler Foundation ... New Jersey Health Foundation. "The experience ...
(Date:9/30/2014)... Calif. , Sept. 30, 2014  Based ... diagnostics market, Frost & Sullivan recognizes Ventana Medical ... Group, with the 2014 North American Frost & ... strict quality practices along with a focus on ... a global leader in tissue-based cancer diagnostic solutions ...
(Date:9/30/2014)... Sept. 30, 2014  Proteomics is a focus ... new report from Kalorama Information.  The healthcare market research ... in proteomics in the past two years.  The ... between private proteomic companies and academic institutions, to ... proteomics innovator companies.  Kalorama observed the industry in ...
Breaking Medicine Technology:Kessler Foundation Partners with New Jersey Health Foundation To Start Innovative Companies To Change the Lives of People with Disabilities 2Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 2Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 3Frost & Sullivan applauds the diversity of Ventana products and services for the cancer diagnostics market 4Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 2Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 3
... 22, 2011 Big ideas are coming out of the ... noticing. The Economist Intelligence Unit says for a country of ... per person. "New Zealanders are known for ... in groundbreaking ways that push the envelope," says Marta Mager, ...
... PediaVision, maker of the new Spot vision screener, announced ... PediaVision screening units to the new Spot vision screener. ... Lions Clubs on-going screening program. Dr. Hauser Weiler, a highly ... Clubs in 1987.  He has dedicated himself to working with ...
Cached Medicine Technology:Cool New Zealand Inventions 2Cool New Zealand Inventions 3Lions Clubs of Virginia Acquire 8 New Spot Vision Screeners 2Lions Clubs of Virginia Acquire 8 New Spot Vision Screeners 3Lions Clubs of Virginia Acquire 8 New Spot Vision Screeners 4
(Date:9/30/2014)... 2014 More than 23 per cent of Canadians report ... stress increases the risk of poor mental and physical health, ... but for others especially those most likely to sweat ... , Thankfully, new research from Concordia University has found a ... huge help for healthcare professionals working to stop stress before ...
(Date:9/30/2014)... September 30, 2014 OZ Naturals ... beauty brand on Amazon.com. , “The majority of our ... beauty categories on Amazon.com,” said Craig Romero, CEO of OZ ... on Amazon.co.uk and Canada on Amazon.ca , Romero went on ... launched earlier last month, are already taking over top positions ...
(Date:9/30/2014)... cannot multiply and cardiac muscles contain few stem ... after a heart attack. Now Tel Aviv University ... in cardiac tissue engineering. , Dr. Tal Dvir ... Department of Biotechnology, Department of Materials Science and ... been developing sophisticated micro- and nanotechnological tools ...
(Date:9/30/2014)... September 30th, 2014 A new report launched ... (The Irish Longitudinal Study on Ageing) conducted by ... Trinity College Dublin, Ireland, has highlighted the serious, ... Ireland,s intellectual disability population. , The IDS-TILDA study ... Europe and the only one in the world ...
(Date:9/30/2014)... MyServer2Go.com made an announcement recently that ... this year for its quality VPS solution, reliable support ... MyServer2Go.com is a professional and targeted website which reviewed ... announcement will help webmasters find the best VPS hosting ... http://www.arvixe.com ) is one of the fastest-growing and most ...
Breaking Medicine News(10 mins):Health News:How to predict who will suffer the most from stress 2Health News:OZ Naturals Now the No. 1 Selling Beauty Brand on Amazon.com 2Health News:OZ Naturals Now the No. 1 Selling Beauty Brand on Amazon.com 3Health News:A heartbeat away? Hybrid 'patch' could replace transplants 2Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 2Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 3Health News:Longitudinal report shows challenging reality of ageing with an intellectual disability 4Health News:Arvixe Is Named Best VPS Hosting by MyServer2Go.com 2
... disease (PD) is a neurological disorder, according to ... the Journal of the American Academy ... disease also increases a person,s risk of experiencing ... Parkinson,s treatment plans include a multidisciplinary approach in ...
... Lunden, the nation,s,longest-running morning news anchor hosted ABC,s ... her tenure she reported from 26 countries, covered,four ... One of the most,visible women in the country, ... Americans about health and wellness through her books, ...
... MAKE IT FIT(TM),( http://www.youcanmakeitfit.com ), an online fitness and ... 2009 by donating,their services for almost nothing. Principals Stacy ... Magnolia state an annual membership to, www.youcanmakeitfit.com for ... hours of,8am to 8pm on Tuesday, January 6, 2009. ...
... the United States , , TUESDAY, Dec. 30 (HealthDay News) ... of Quebec, population 7 million-plus, more than $6.5 billion ... from Seattle to Tampa are costing the United States, ... director of the Institute for Sleep and Wake Disorders ...
... Experts offer tips on how to avoid injury while ... -- Clearing snow from your driveway and sidewalks can ... to take proper health and safety precautions, says the ... 2007, more than 118,000 people were treated in U.S. ...
... pay more attention to choosing the doctor, not the ... viewed as a safe and long-lasting way to alleviate ... procedure fails, the problem more often lies with surgical ... found. , , Dislocation of the implant was the most ...
Cached Medicine News:Health News:Parkinson's Disease Plays Havoc With Common Orthopaedic Conditions 2Health News:Parkinson's Disease Plays Havoc With Common Orthopaedic Conditions 3Health News:Joan Lunden Inks Three-Year Deal to Host Health Corner(R) Television Series 2Health News:MAKE IT FIT(TM) Offers Virtually Free Fitness Service to All Mississippi Residents on 'Make Mississippi Fit Day' 2Health News:Insomnia Costs Billions in Lost Productivity 2Health News:Insomnia Costs Billions in Lost Productivity 3Health News:Shovel Snow Safely 2Health News:Surgeons Often Are Blamed When Hip Replacements Fail 2Health News:Surgeons Often Are Blamed When Hip Replacements Fail 3
...
... The Slim-LOC Plate is a ... intervertebral body fixation. The Slim-LOC is ... design, modified by current market technology. ... versatility & integrated instrumentation. Reduced width ...
... Osmium is a cervical plate system ... spine. The implant provides for the ... the bone transplant has consolidated. Optimized ... and bicortical fixation. Maximum purchase also ...
... meet the clinical challenges of anterior cervical ... and the choice of fixed angle screws ... for ease of implantation in complex cases. ... the surgeon the versatility of creating a ...
Medicine Products: